Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.

Daniels LB, Grady D, Mosca L, Collins P, Mitlak BH, Amewou-Atisso MG, Wenger NK, Barrett-Connor E; Raloxifene Use for the Heart (RUTH) Trial Investigators.

Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):164-70. doi: 10.1161/CIRCOUTCOMES.112.966986. Epub 2013 Mar 12.

PMID:
23481531
[PubMed - indexed for MEDLINE]
Free Article
2.

Safety of anacetrapib in patients with or at high risk for coronary heart disease.

Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM, Stepanavage M, Liu SX, Gibbons P, Ashraf TB, Zafarino J, Mitchel Y, Barter P; Determining the Efficacy and Tolerability Investigators.

N Engl J Med. 2010 Dec 16;363(25):2406-15. doi: 10.1056/NEJMoa1009744. Epub 2010 Nov 17.

PMID:
21082868
[PubMed - indexed for MEDLINE]
Free Article
3.

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.

Cannon CP, Dansky HM, Davidson M, Gotto AM Jr, Brinton EA, Gould AL, Stepanavage M, Liu SX, Shah S, Rubino J, Gibbons P, Hermanowski-Vosatka A, Binkowitz B, Mitchel Y, Barter P; DEFINE investigators.

Am Heart J. 2009 Oct;158(4):513-519.e3. doi: 10.1016/j.ahj.2009.07.028.

PMID:
19781408
[PubMed - indexed for MEDLINE]
4.

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R; SEAS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2.

PMID:
18765433
[PubMed - indexed for MEDLINE]
Free Article
5.

Echocardiographic assessment of ejection fraction in left ventricular hypertrophy.

Wandt B, Bojö L, Tolagen K, Wranne B.

Heart. 1999 Aug;82(2):192-8.

PMID:
10409535
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.

Nilsson OR, Atterhög JH, Castenfors J, Jorfelt L, Karlberg BE, Thulin T, Tolagen K, Wettre S, Ohman KP.

Acta Med Scand. 1984;216(3):301-7.

PMID:
6388253
[PubMed - indexed for MEDLINE]
7.

Timolol and hydrochlorothiazide-amiloride in primary hypertension.

Henning R, Karlberg BE, Odar-Cederlöf I, Andersson PO, Lins LE, Nilsson OR, Tolagen K.

Clin Pharmacol Ther. 1980 Dec;28(6):707-14.

PMID:
7002427
[PubMed - indexed for MEDLINE]
8.

Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study.

Scherstén B, Thulin T, Kuylenstierna J, Engström M, Karlberg BE, Tolagen K, Nordlander S, Nilsson G.

Hypertension. 1980 Sep-Oct;2(5):672-9.

PMID:
6998872
[PubMed - indexed for MEDLINE]
Free Article
9.

Effects of prazosin on plasma renin activity and blood pressure.

Karlberg BE, Thulin T, Fagerberg SE, Schersten B, Tolagen K, Vikesdal O, Malmberg L.

J Clin Pharmacol. 1979 Jul;19(7):357-65. No abstract available.

PMID:
479380
[PubMed - indexed for MEDLINE]
10.

Once-daily metoprolol in primary hypertension.

Karlberg BE, Nilsson O, Tolagen K, Nitelius E, Waern U.

Clin Pharmacol Ther. 1979 Apr;25(4):399-407.

PMID:
371902
[PubMed - indexed for MEDLINE]
11.

Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.

Nilsson OR, Karlberg BE, Ohlsson O, Thulin T, Tolagen K.

Acta Med Scand. 1979;206(4):303-8.

PMID:
506802
[PubMed - indexed for MEDLINE]
12.

Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes.

Tolagen K, Karlberg BE.

Acta Med Scand. 1979;205(7):557-62.

PMID:
474181
[PubMed - indexed for MEDLINE]
13.
14.

Age, blood pressure, renin and urinary electrolytes in primary hypertension and in the normotensive state.

Karlberg BE, Tolagen K.

Scand J Clin Lab Invest. 1978 Jun;38(4):319-27.

PMID:
684365
[PubMed - indexed for MEDLINE]
15.

Plasma and urinary aldosterone and their interrelations with blood pressure, plasma renin activity and urinary electrolytes in normotensive subjects.

Tolagen K, Karlberg BE.

Scand J Clin Lab Invest. 1978 May;38(3):241-7.

PMID:
663548
[PubMed - indexed for MEDLINE]
16.
17.

Relationships between blood pressure, age, plasma renin activity and electrolyte excretion in normotensive subjects.

Karlberg BE, Tolagen K.

Scand J Clin Lab Invest. 1977 Oct;37(6):521-8.

PMID:
616070
[PubMed - indexed for MEDLINE]
18.

Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone.

Karlberg BE, Nilsson O, Tolagen K.

Curr Ther Res Clin Exp. 1977 Jan;21(1):10-20. No abstract available.

PMID:
401703
[PubMed - indexed for MEDLINE]
19.

Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.

Kralberg BE, Tolagen K.

Am J Med. 1976 May 31;60(6):891-6.

PMID:
14504
[PubMed - indexed for MEDLINE]
20.

Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.

Karlberg BE, Kågedal B, Tegler L, Tolagen K, Bergman B.

Am J Cardiol. 1976 Mar 31;37(4):642-9.

PMID:
769527
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk